Phase 3 Early Breast Cancer Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 3
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Early Breast Cancer
Novartis Pharmaceuticals1,400 enrolled217 locationsNCT05827081
Recruiting
Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast Cancer (Early Breast Cancer)
AstraZeneca5,500 enrolled794 locationsNCT05952557
Recruiting
Phase 3
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Breast Cancer (Early Breast Cancer)
AstraZeneca4,300 enrolled711 locationsNCT05774951
Recruiting
Phase 3
EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast Cancer
HER2 Positive Early Breast Cancer
Fudan University1,406 enrolled1 locationNCT05883852
Completed
Phase 3
SNAC2: A randomised phase III study to determine in women with early breast cancer whether sentinel node based management increases the risk of loco-regional recurrence and in particular, axillary clearance, compared with axillary clearance with any subgroup of women
Operable early breast cancer
National Health & Medical Research Council (NHMRC)1,012 enrolled2 locationsACTRN12605000409673
Completed
Phase 3
Radiotherapy in Early Breast Cancer
Node positive or high risk node negative early Breast Cancer
National Cancer Institute of Canada (NCIC)1,822 enrolled1 locationACTRN12606000523505
Completed
Phase 3
Adjuvant tamoxifen - longer against shorter
Early Breast Cancer
Breast Cancer Trials20,000 enrolled1 locationACTRN12606000533594